OG-232

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOG-232
Drug Alias NameLSD-1 inhibitor (Oryzon Genomics)OG-232
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOryzon Genomics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOryzon Genomics Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A